ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Infection and Immunity

• Publication date

  1988-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/iai.56.8.1934-1941.1988PMID 3135265PMCID PMC259504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the S-1 catalytic subunit of pertussis toxin in Escherichia coli

  1987cited by this paper
• Construction and characterization of Bordetella pertussis toxin mutants

  1987cited by this paper
• Active site of Pseudomonas aeruginosa exotoxin A. Glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of diphtheria toxin.

  1987cited by this paper
• Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli

  1987cited by this paper
• Expression and immunological properties of the five subunits of pertussis toxin

  1987cited by this paper
• Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication.

  1986influential reference
• Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.

  1986cited by this paper
• Pertussis toxin gene: nucleotide sequence and genetic organization.

  1986cited by this paper
• Photoaffinity labeling of diphtheria toxin fragment A with NAD: structure of the photoproduct at position 148.

  1985cited by this paper
• Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity.

  1985cited by this paper
• Rapid and sensitive protein similarity searches.

  1985cited by this paper
• Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites.

  1985cited by this paper
• The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.

  1985cited by this paper
• Development of a pertussis component vaccine in Japan.

  1984cited by this paper
• Tn5-induced mutations affecting virulence factors of Bordetella pertussis

  1983cited by this paper
• The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein.

  1983cited by this paper
• New M13 vectors for cloning.

  1983cited by this paper
• Modulation by islet-activating protein of adenylate cyclase activity in C6 glioma cells.

  1982cited by this paper
• Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.

  1982influential reference
• Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis

  1981cited by this paper
• Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase.

  1976cited by this paper
• Interaction of fragment A from diphtheria toxin with nicotinamide adenine dinucleotide.

  1974cited by this paper
• Fluorescence studies of nucleotides binding to diphtheria toxin and its fragment A.

  1974cited by this paper

• State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens

  2025cites this paper
• Designing a New Multi-Epitope Pertussis Vaccine with Highly Population Coverage Based on a Novel Sequence and Structural Filtration Algorithm

  2019cites this paper
• A binding motif for Hsp90 in the A chains of ADP‐ribosylating toxins that move from the endoplasmic reticulum to the cytosol

  2019cites this paper
• Label-Free Cell Phenotypic Identification of Active Compounds in Traditional Chinese Medicines

  2015cites this paper
• LPA0311: cepa de Bordetella pertussis modificada genéticamente para la producción del toxoide pertúsico PT-S1-9K/129G

  2015cites this paper
• KATP channels in the nodose ganglia mediate the orexigenic actions of ghrelin

  2015cites this paper
• Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines

  2014cites this paper
• Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family

  2013cites this paper
• Progesterone directly and rapidly inhibits GnRH neuronal activity via progesterone receptor membrane component 1.

  2012cites this paper
• GPCRs regulate the assembly of a multienzyme complex for purine biosynthesis

  2011cites this paper
• LIGAND-DIRECTED FUNCTIONAL SELECTIVITY AT THE OPIOID RECEPTOR FAMILY: AN EPIC APPROACH TO UNDERSTANDING OPIOID RECEPTOR SIGNALING

  2011cites this paper
• Development of safer pertussis DNA vaccine expressing non-toxic C180 polypeptide of pertussis toxin S1 subunit.

  2007cites this paper
• CHAPTER 12 – Molecular, functional, and evolutionary aspects of ADP-ribosylating toxins

  2006cites this paper
• Structural and immunological studies of pertussis toxin: effect of toxoiding

  2002cites this paper
• Toxin-Based Vaccines (Diphtheria, Tetanus, Pertussis)

  1999cites this paper
• Novel molecular biology approaches to acellular vaccines.

  1996cites this paper
• Acellular pertussis vaccines: a turning point in infant and adolescent vaccination.

  1996cites this paper
• Structural Insights into Pertussis Toxin Action

  1996cites this paper
• The family of bacterial ADP-ribosylating exotoxins

  1995cites this paper
• Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.

  1995cites this paper
• Both allelic forms of the rat T cell differentiation marker RT6 display nicotinamide adenine dinucleotide (NAD)‐glycohydrolase activity, yet only RT6.2 is capable of automodification upon incubation with NAD

  1995cites this paper
• Cellular immunity in relation to pertussis vaccination and infection.

  1995cites this paper
• Probing the structure‐activity relationship of Escherichia coli LT‐A by site‐directed mutagenesis

  1994cites this paper
• Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin.

  1994cites this paper
• Expression and mutagenesis of recombinant cholera toxin A subunit.

  1994cites this paper
• Biochemical analysis of mutations at tyrosine-98 of the S1 subunit of pertussis toxin.

  1994cites this paper
• ADP-Ribosylation of Signal-Transducing Guanine Nucleotide Binding Proteins by Cholera and Pertussis Toxin

  1994cites this paper
• The New Generation of Recombinant Pertussis Vaccines

  1994cites this paper
• The crystal structure of pertussis toxin.

  1994cites this paper
• AB5 ADP-ribosylating toxins: comparative anatomy and physiology.

  1994cites this paper
• Evidence for a catalytic role of glutamic acid 129 in the NAD-glycohydrolase activity of the pertussis toxin S1 subunit.

  1993cites this paper
• Site-specific alterations in the B oligomer that affect receptor- binding activities and mitogenicity of pertussis toxin

  1993cites this paper
• Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin

  1992cites this paper
• NAD+ binding site of Clostridium botulinum C3 ADP-ribosyltransferase. Identification of peptide in the adenine ring binding domain using 2-azido NAD.

  1992cites this paper
• Pertussis toxin and target eukaryotic cells: binding, entry, and activation

  1992cites this paper
• Expression of bacterial cytotoxin genes in mammalian target cells

  1992cites this paper
• Recombinant acellular pertussis vaccine--from the laboratory to the clinic: improving the quality of the immune response.

  1992cites this paper
• Development and clinical testing of an acellular pertussis vaccine containing genetically detoxified pertussis toxin.

  1992cites this paper
• Progress towards the development of new vaccines against whooping cough.

  1992cites this paper
• ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin.

  1992cites this paper
• Detoxification of pertussis toxin by site-directed mutagenesis: a review of connaught strategy to develop a recombinant pertussis vaccine.

  1991cites this paper
• Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin

  1991cites this paper
• The carboxyl terminus of the S1 subunit of pertussis toxin confers high affinity binding to transducin.

  1991cites this paper
• Genetic approaches to a vaccine for pertussis.

  1991cites this paper
• Binding of NAD+ to pertussis toxin.

  1991cites this paper
• Protease treatment of pertussis toxin identifies the preferential cleavage of the S1 subunit.

  1991cites this paper
• Towards third-generation whooping cough vaccines.

  1991cites this paper
• Computer modelling of the NAD binding site of ADP‐ribosylating toxins: active‐site structure and mechanism of NAD binding

  1991cites this paper
• Development of non-toxigenic vaccine strains of Bordetella pertussis by gene replacement.

  1991cites this paper
• PROTEIN CONFORMATION AFFECTS THE EFFICACY OF PERTUSSIS VACCINES

  1991cites this paper
• Localization of a region of the S1 subunit of pertussis toxin required for efficient ADP-ribosyltransferase activity.

  1991cites this paper
• Vaccins a-cellulaires contre la coqueluche

  1991cites this paper
• Gene Replacement in Bordetella pertussis by Transformation with Linear DNA

  1990cites this paper
• Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.

  1990cites this paper
• Recognition of pertussis toxin by antibodies to synthetic peptides.

  1990cites this paper
• Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+.

  1990cites this paper
• Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough

  1990cites this paper
• The role of cysteine 41 in the enzymatic activities of the pertussis toxin S1 subunit as investigated by site-directed mutagenesis.

  1990cites this paper
• Biochemical and biological activities of recombinant S1 subunit of pertussis toxin

  1990cites this paper
• Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin

  1990cites this paper
• Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine

  1990cites this paper
• The subunit S1 is important for pertussis toxin secretion.

  1990cites this paper
• Photolabeling of Glu-129 of the S-1 subunit of pertussis toxin with NAD

  1989cites this paper
• Role of tryptophan 26 in the NAD glycohydrolase reaction of the S-1 subunit of pertussis toxin.

  1989cites this paper
• Effects of mutations on enzyme activity and immunoreactivity of the S1 subunit of pertussis toxin

  1989cites this paper
• Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map

  1989cites this paper
• Detoxification of pertussis toxin by site-directed mutagenesis.

  1989cites this paper
• Mutants of pertussis toxin suitable for vaccine development.

  1989cites this paper
• Expression and secretion of the S-1 subunit and C180 peptide of pertussis toxin in Escherichia coli

  1989cites this paper
• Cloning, nucleotide sequence, and hybridization studies of the type IIb heat-labile enterotoxin gene of Escherichia coli

  1989cites this paper
• Cloning, Nucleotide Sequence, and Hybridization Studies of the Type Ilb Heat-Labile Enterotoxin Gene of Escherichia coli

  year unknowncites this paper
• Ilb Heat-Labile Enterotoxin Gene of Escherichia coli

  year unknowncites this paper